Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children’s Oncology Group report

Despite aggressive chemotherapy including mitoxantrone and etoposide, relapse occurs for almost half of children with acute myeloid leukemia (AML). Since both drugs inhibit topoisomerase II and cause DNA double strand breaks, resistance could be achieved by enhanced DNA damage repair (DDR), via homo...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Xin, Gerbing, Robert B., Alonzo, Todd A., Redell, Michele S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685730/
https://www.ncbi.nlm.nih.gov/pubmed/29163809
http://dx.doi.org/10.18632/oncotarget.21363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685730/
https://www.ncbi.nlm.nih.gov/pubmed/29163809
http://dx.doi.org/10.18632/oncotarget.21363

Ejemplares similares